PharmaShots Weekly Snapshots (Feb 15- 19, 2021)

 PharmaShots Weekly Snapshots (Feb 15- 19, 2021)

PharmaShots Weekly Snapshots (Feb 15- 19, 2021)

RedHill Signs a Manufacturing Agreement with Cosmo for Movantik and RHB-204 

Published: Feb 19, 2021 | Tags: RedHill, Signs, Manufacturing, Agreement, Cosmo, Movantik, RHB-204

Astellas and Seagen Reports Submission of Two BLA to the US FDA for Padcev (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer

Published: Feb 19, 2021 | Tags: Astellas, Seagen, Reports, Submission, Two, BLA, US, FDA, Padcev (enfortumab vedotin), Locally, Advanced, Metastatic, Urothelial Cancer

The US FDA Approves Patient Specific Talus Spacer to Treat AVN of Ankle Joint as a Humanitarian Use Device

Published: Feb 19, 2021 | Tags: US, FDA, Approves, Patient, Specific, Talus Spacer, Treat, AVN, Ankle Joint, Humanitarian, Use, Device

Dermavant Report Results of Tapinarof Cream in P-III PSOARING 3 Study with Durable and Remittive Benefits for Plaque Psoriasis

Published: Feb 19, 2021 | Tags: Dermavant, Report, Results, Tapinarof Cream, P-III, PSOARING 3, Study, Durable, Remittive Benefits, Plaque Psoriasis

Fresenius Kabi Launches Idacio (biosimilar, adalimumab) for Multiple Chronic Inflammatory Conditions in Canada

Published: Feb 19, 2021 | Tags: Fresenius Kabi, Launches, Idacio (biosimilar, adalimumab), Multiple Chronic Inflammatory, Conditions, Canada

Lilly Collaborates with Rigel to Develop RIPK1 Inhibitors for Immunological and Neurodegenerative Diseases

Published: Feb 19, 2021 | Tags: Lilly, Collaborates, Rigel, Develop, RIPK1 Inhibitors, Immunological ,Neurodegenerative Diseases

BeiGene Reports the US FDA’s Acceptance of sNDA for Brukinsa (zanubrutinib) in Waldenström’s Macroglobulinemia

Published: Feb 18, 2021 | Tags: BeiGene, Reports, US, FDA, Acceptance, sNDA, Brukinsa (zanubrutinib), Waldenström’s Macroglobulinemia


Myovant and Pfizer Publish the Results of Relugolix Combination Regimen in P-III LIBERTY Studies in NEJM

Published: Feb 18, 2021 | Tags: Myovant, Pfizer, Publish, Results, Relugolix, Combination, Regimen ,P-III, LIBERTY, Studies, NEJM

GSK Expand its 2020 Collaboration with Vir to Advance New Therapies for Influenza and Other Respiratory Viruses

Published: Feb 18, 2021 | Tags: GSK, Expand, 2020, Collaboration, Vir, Advance, New, Therapies,  Influenza, Other, Respiratory, Viruses

Novartis Collaborates with Bill & Melinda Gates Foundation to Discover and Develop Gene Therapy for Sickle Cell Disease

Published: Feb 18, 2021 | Tags: Novartis, Collaborates, Bill & Melinda, Gates Foundation, Discover ,Develop, Gene Therapy, Sickle Cell Disease

Lilly Reports Results of Tirzepatide in P-lll SURPASS-3 and 5 Trials for Type-2 Diabetes

Published: Feb 18, 2021 | Tags: Lilly, Reports, Results, Tirzepatide, P-lll, SURPASS-3 and 5, Trials, Type-2 Diabetes

Coherus Reports the US FDA’s Acceptance of BLA for CHS-1420 (biosimilar, adalimumab)

Published: Feb 18, 2021 | Tags: Coherus, Reports, US, FDA, Acceptance, BLA, CHS-1420 (biosimilar, adalimumab)

Boehringer Ingelheim Animal Health Establishes Pawru for its PetPro Portfolio

Published: Feb 17, 2021 | Tags: Boehringer Ingelheim, Animal Health, Establishes, Pawru,  PetPro Portfolio

Novartis’s Entresto Receives US FDA’s Approval for Chronic Heart Failure

Published: Feb 17, 2021 | Tags: Novartis, Entresto, Receives, US, FDA, Approval, Chronic Heart Failure

GSK Initiates P-III study for RSV Candidate Vaccine Programme for Older Adults

Published: Feb 17, 2021 | Tags: GSK, Initiates, P-III study, RSV, Candidate, Vaccine, Programme, Older, Adults

Novartis Report Results of Kesimpta (ofatumumab) Sensoready Autoinjector Pen for Multiple Sclerosis

Published: Feb 17, 2021 | Tags: Novartis, Report, Results, Kesimpta (ofatumumab), Sensoready, Autoinjector Pen, Multiple Sclerosis

BMS and Acceleron’s Reblozyl (Luspatercept) Receives Health Canada Approval for Adult Patients With Myelodysplastic Syndromes

Published: Feb 17, 2021 | Tags: BMS and Acceleron, Reblozyl (Luspatercept), Receives, Health Canada, Approval, Adult Patients, Myelodysplastic Syndromes

Guardant Health Launches Guardant Reveal Liquid Biopsy Test for Early-Stage Colorectal Cancer

Published: Feb 17, 2021 | Tags: Guardant Health, Launches, Guardant Reveal, Liquid, Biopsy Test, Early Stage, Colorectal Cancer

Onward Signs a Worldwide Exclusive License and Co-Development Agreement with Biomunex for Immuno-Oncology

Published: Feb 16, 2021 | Tags: Onward, Signs, Worldwide, Exclusive, License, Co-Development ,Agreement, Biomunex, Immuno-Oncology

Aker BioMarine Collaborate with Université de Sherbrooke Department of Medicine for Alzheimer’s Disease

Published: Feb 16, 2021 | Tags: Aker BioMarine, Collaborate, Université de Sherbrooke, Department, Medicine, Alzheimer’s Disease

AstraZeneca and Serum Institute of India’s COVID-19 Vaccine Receive WHO’s EUA to Prevent COVID-19

Published: Feb 16, 2021 | Tags: AstraZeneca and Serum Institute of India, COVID-19 Vaccine, Receive ,WHO, EUA, Prevent, COVID-19

Targovax Receives US FDA’s Fast Track Designation for ONCOS-102 for Malignant Pleural Mesothelioma

Published: Feb 16, 2021 | Tags: Targovax, Receives, US, FDA, Fast Track Designation, ONCOS-102,  Malignant Pleural Mesothelioma

Celltrion Receives EC’s Approval for Yuflyma (biosimilar, adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases

Published: Feb 16, 2021 | Tags: Celltrion, Receives, EC, Approval, Yuflyma (biosimilar, adalimumab), Treatment, Multiple Chronic Inflammatory,, Diseases

Exelixis Report Results of Cabometyx (cabozantinib) in P-II PAPMET Study for Patients with Metastatic Papillary Renal Cell Carcinoma

Published: Feb 16, 2021 | Tags: Exelixis, Report, Results, Cabometyx (cabozantinib), P-II, PAPMET Study, Patients, Metastatic, Papillary, Renal Cell Carcinoma

Roche’s Receives the US FDA’s Clearance for Urine Sample Type for BK Virus Quantitative Test

Published: Feb 15, 2021 | Tags: Roche, Receives, US, FDA, Clearance, Urine Sample, Type, BK Virus, Quantitative Test

Biocon Biologics and Viatris Receive EC’s Approval for Kixelle (biosimilar, insulin aspart) for Diabetes Mellitus

Published: Feb 15, 2021 | Tags: Biocon Biologics and Viatris, Receive, EC, Approval, Kixelle (biosimilar, insulin aspart), Diabetes Mellitus

Merck Report Result of Keytruda (pembrolizumab) + Lenvima (lenvatinib) as 1L Treatment for Advanced Renal Cell Carcinoma

Published: Feb 15, 2021 | Tags: Merck, Report, Result, Keytruda (pembrolizumab) + Lenvima (lenvatinib), 1L, Treatment, Advanced Renal Cell Carcinoma

Pfizer’s Panzyga Receives the US FDA’s Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy

Published: Feb 15, 2021 | Tags: Pfizer, Panzyga, Receives, US, FDA, Approval, sBLA, Chronic Inflammatory, Demyelinating, Polyneuropathy

Takeda Report Results of TAK-620 (maribavir) in P-III SOLCTICE Trial for the Treatment of Post-Transplant Patients with Cytomegalovirus Infection

Published: Feb 15, 2021 | Tags: Takeda, Report, Results, TAK-620 (maribavir), P-III, SOLCTICE Trial, Treatment, Post Transplant, Patients, Cytomegalovirus Infection

G1 Therapeutics’ Cosela (trilaciclib) Receives US FDA’s Approval as the First Myeloprotection Therapy for Extensive-Stage Small Cell Lung Cancer

Published: Feb 15, 2021 | Tags: G1 Therapeutics, Cosela (trilaciclib), Receives, US, FDA, Approval, First, Myeloprotection, Therapy, Extensive Stage, Small Cell, Lung Cancer

Related post: PharmaShots Weekly Snapshots (Feb 08 – 12, 2021)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post